The newly isolated peptide, endothelin-1 (ET-1), is a potent pressor agent that reduces GFR and the glomerular ultrafiltration coefficient. Recent evidence demonstrates that ET-1 mobilizes intracellular Ca2" (ICa2+Ii) in glomerular mesangial cells by activating the phosphoinositide cascade. The present experiments were designed to examine whether ET-1 stimulates mesangial cell contraction and regulates the synthesis of PGE2 and cAMP, which dampen vasoconstrictor-induced mesangial contraction. ET-1 (2 1 nM) reduced the cross-sectional area of rat mesangial cells cultured on three-dimensional gels of collagen type I. ET-1 also caused complex rearrangements of F-actin microfilaments consistent with a motile response. Contraction in response to ET-1 occurred only at concentrations that activate phospholipase C, and contraction was unaffected by blockade of dihydropyridine-sensitive C(a2+ channels.
Introduction
Endothelin-l (ET-1)I is a member of a family of peptides synthesized by endothelial and other cell types in vitro and in vivo (1) (2) (3) . Endothelin peptides arise from at least three preproendothelin species, which after proteolysis yield different isoforms (ET-1, -2, and -3, [l-3] ).2 ET-1 contracts diverse smooth muscle preparations in vitro (1, 3, 4) , and when injected in vivo ET-1 is a potent vasoconstrictor ( 1, 3) , particularly in the renal vasculature (5) (6) (7) (8) (9) (10) .
Recent experiments demonstrate a role for ET-1 in the control of glomerular hemodynamics. Miller et al. (8) and King et al. (9) found that ET-1 decreased both GFR and renal plasma flow; a disproportionate decline in renal plasma flow caused the filtration fraction to fall. Using micropuncture, Badr and co-workers (10) documented increased glomerular afferent and efferent arteriolar resistance and a dramatic decline in the ultrafiltration coefficient, Kf, in response to ET- 1. Although the precise mechanism controlling Kf remains uncertain, the currently favored hypothesis is that contraction of mesangial cells, which are glomerular microvascular pericytes, decreases Kf by reducing filtration surface area (see 1 1-13 for review). We previously reported that ET-1 evokes two distinct patterns of Ca2' signaling in cultured rat mesangial cells ( 14) . ET-l at 0.1-10.0 pM caused a modest but sustained elevation of [Ca2+]1 that depended on Ca2' entry. In contrast, higher doses of ET-1 (0.1-100.0 nM) caused a rapid, transient increase in [Ca2+]i followed by a lower, sustained phase (14) . The transient phase of [Ca2+]J correlated with activation of phospholipase C and the release of inositol-1,4,5-trisphosphate, which mobilizes Ca2' from intracellular stores (15) . These data implicate activation of the phosphoinositide cascade as an initial event leading to endothelin-induced biological changes, possibly including contraction of mesangial cells via pharmacomechanical coupling.
Using cultured rat mesangial cells, the present experiments were designed to examine whether ET-1 causes mesangial cell contraction and stimulates synthesis of two negative feedback signals, prostaglandin E2 (PGE2) and cAMP, which dampen mesangial contraction (11, 12, 16) . Our experiments provide evidence that ET-l (a) stimulates mesangial contraction which correlates with activation of the phosphoinositide cascade; (b) increases [3H]arachidonate release and PGE2, PGF2., and TXB2 synthesis; and (c) amplifies j-adrenergic-stimulated cAMP accumulation via a PGE2-dependent mechanism.
Corp. (Palo Alto, CA). Arginine vasopressin (AVP), 12-tetradecanoyl phorbol 13 -acetate (TPA), ionomycin, nifedipine, and Bay K 8644 were obtained from Calbiochem-Behring Corp. (La Jolla, CA). Rhodamine-phalloidin and fura-2 acetoxymethylester were from Molecular Probes (Grand Junction, OR). [5,6,8,9,11,12,14,15- Mesangial cell culture and contraction assays. Rat mesangial cell strains in passages 5-15, cultured and characterized as reported (17) , were subcultured onto three-dimensional, type I collagen gels in LabTek (Nunc) culture slides for measurements ofcell contraction. Type I collagen gels were prepared by mixing 8.0 ml of 2.9 mg/ml collagen in 0.012 N HCl, 1.0 ml of 1 N NaOH, and 1.0 ml of 10X Minimal Essential Medium, all from sterile solutions at 4VC, and adjusting to pH 7.4. Aliquots (1 ml) were plated into two-chamber Lab-Tek slides and gelation was initiated by warming to 370C for I h. Contraction was tested 24 h after subculture onto the collagen gel by incubating cells plus or minus agonists in Hanks' balanced salt solution containing 1.6 mM CaC12, 0.8 mM MgSO4, 10 mM Hepes (pH 7.4), and 2 mg/ml fatty acid-free bovine serum albumin (HBSS-II), and the change in cross-sectional area over time was measured using computer-aided microscopy as previously described (17) . A cell was scored positive for contraction with a decrease in cross-sectional area 2 7%. The significance of responding cells was tested by Chi-squared analysis (18) .
Staining ofF-actin microfilaments. 24 h after subculture into fourchamber Lab Tek slides, mesangial cells were incubated with HBSS-II alone or with agonists for 30 min at 23°C. To evaluate cytoskeletal arrangements, cells were rinsed, twice, with Dulbecco's PBS (DPBS), fixed with 0.5 ml 3.7% formaldehyde in DPBS for 10 min at 23°C, rinsed, twice, with DPBS, permeabilized with 0.5 ml 0.2% Triton X-100 in DPBS (vol/vol) for 1 min at 23°C, and rinsed again, three times, with DPBS. Cells were then treated with 0.2 ml 5.0 U/ml rhodamine-phalloidin for 30 min at 23°C on a rotary shaker in the dark. After rinsing, twice, with DPBS, cells were mounted under glycerol/ DPBS (1:1), sealed, and photographed using a Leitz microscope with a mercury lamp, epifluorescence illumination, and Kodak TMax film. The photomicrographs in Fig. 3 
Results
ET-J reduces cross-sectional area of mesangial cells. We assessed the contractile actions of ET-1 using mesangial cells cultured on three-dimensional collagen gels. When ET-1 was added at 0.1 M, 48% of cells demonstrated a marked reduction of cross-sectional area at 30 min (arrows in Fig. 1 , Table  I ). Cross-sectional area in the responding cells fell by an average of 42%, but in some cells reductions of 60-70% were seen. Contraction most often occurred along the long axis ofthe cell, although in many cells the cell body was also reduced (Fig. 1) . Only 4.3% of control cells (i.e., HBSS-II alone) showed a significant (i.e., > 7%) reduction in cross-sectional area ( Fig. 1 , Table I ). 1 pM ET-1, which generates only a monophasic, slow but sustained elevation of [Ca2+], (14) , failed to induce mesangial cell contraction (Table I ). In contrast, two concentrations of ET-1 (1.0 nM and 0.1 ,uM) that mobilize intracellular Ca2+ via activation of phospholipase C (14) increased the percentage of contracted cells above control (Table I) (Table I) . These data are consistent with ET-1-induced contraction of mesangial cells via pharmacomechanical coupling (i.e., activation of phospholipase C) and fail to support a role for DHP-sensitive Ca 2 channels.
As shown in Fig. 3 , we examined the arrangement of actin microfilaments in mesangial cells treated with ET-I and ionomycin (Fig. 3) . In control cells incubated for 30 AVP. ET-1 also increased production of immunoassayable PGE2, PGF2a, and TXB2 (Fig. 4 B) . ET-1 at 0.1 sM generated a fivefold increase in PGE2 synthesis; by comparison, 0. Control lonomyci n Figure 3 . ET-I and ionomycin cause complex rearrangements of F-actin microfilament bundles in mesangial cells. Cells on glass chamber slides were treated with HBSS-II (A, B), 0.1 uM ET-I (C, D), or 10 MM ionomycin (E, F) as described in Fig. 1 . The cells were then fixed in formaldehyde, permeabilized with Triton X-100, stained with rhodamine-phalloidin, and photographed under fluorescence microscopy as described in Methods. Specific properties of cell structure identified by arrows are described in the text. X160. (Table II) . Preincubation with 10 MM SQ29,548 likewise had no effect in either control incubations or in incubations with ET-1 ( Table   Table II II). Thus we conclude that in cultured rat mesangial cells, inhibition of cyclooxygenase or blockade of TXA2 receptors have no effect on ET-1-induced reductions of mesangial cell cross-sectional area, suggesting that PGF2a and TXB2 do not mediate contraction induced by ET-1. In addition, even though indomethacin amplified basal contraction by mesangial cells, the amount of PGE2 produced subsequent to ETstimulated phospholipase A2 activity was not sufficient by itself to dampen ET-l-induced contraction on collagen gels.
ET-J potentiates , adrenergic-stimulated accumulation of intracellular cAMP. Similar to the model for regulation of smooth muscle cell contraction (25) , the concentration of intracellular cAMP is thought to be an important negative-feedback signal to dampen vasoconstrictor-induced mesangial cell contraction (1 1-13, 16 ). Thus we investigated whether ET-1 would stimulate cAMP accumulation in cultured mesangial cells. When added alone, 0.1 MuM ET-1 failed to elevate intracellular cAMP (Fig. 5) . Added in the presence of 0.1 mM IBMX, which magnifies 1.0 MM isoproterenol-stimulated cAMP 6.2-fold (189±17 fmol/Mg protein per 3 min without IBMX vs. 1,169±67 with IBMX, mean+SEM, n = 4-6 in duplicate), ET-1 modestly increased intracellular cAMP over basal levels (basal = 40±5 vs. 0.1 MM ET-l = 85±10, mean±SEM, n = 5 in duplicate). However, coincubation with ET-1 (0.1 MM), in the absence of IBMX, nearly doubled isoproterenol-stimulated cAMP accumulation (Fig. 5) . Ionomycin (10MM) and TPA (0.1 M m), either alone or in combination, were unable to mimic the potentiation of cAMP synthesis by ET-l (Fig. 5) . Indeed ionomycin reduced isoproterenol-stimulated cAMP synthesis, which has been ascribed to Ca2+-mediated activation of phosphodiesterase (26) . Neither TPA nor ionomycin affected basal cAMP levels. On the other hand, 10 AM indomethacin, which inhibits > 95% of cyclooxygenase activity in mesangial cells (24) , had no effect on basal cAMP levels but blocked potentiation of isoproterenol-stimulated cAMP by ET-I (Fig. 5) . Addition of PGE2 to an extracellular concentration (10 nM) similar to that stimulated by 0.1 uM ET-1 (Fig. 4 B) 
Discussion
There is accumulating evidence that the biological functions of ET-are of considerable importance in the kidney. ETmarkedly increases renal vascular resistance and decreases renal blood flow, glomerular filtration rate, and Kf (5-10). In the rat ET-at low doses modestly increases NaCl excretion (9) and decreases renin secretion from isolated glomeruli (27) .
In the dog ET-1 decreases NaCi excretion and increases plasma renin activity (8) . We (14) and others (10) (32) and bovine retinal microvascular pericytes (33) . Mesangial cells on collagen gels expressed more abundant cytoplasmic extensions than cells on polystyrene, and these cells closely resemble the phenotype of mesangial cells in vivo (29, 30) . In vivo these cytoplasmic extensions are dense with contractile filaments (29, 30) and are thought to play a vital function in the control of Kf by mesangial contraction (1 1-13, 16, 30 ). ET-1 -induced contraction occurred in the cell body but was pronounced in the cytoplasmic extensions and along the long axis of the cell (Fig. 1) (Table II) . Likewise the concentration of PGE2 produced (-10 nM) in mesangial cells was insufficient to activate adenylate cyclase above basal levels (Fig.  5) . The threshold for activation of adenylate cyclase by PGE2 is 2 100 nM in cultured mesangial cells (24) . In contrast, in the present experiments ET-1 nearly doubled cAMP production by isoproterenol (Fig. 5) . Agonists that trigger the phosphoinositide cascade have been reported to potentiate , adrenergic-stimulated cAMP accumulation by a protein kinase C-dependent pathway (26, (34) (35) (36) , although the biochemical mechanism remains unclear. For example, Nakiba et al. (37) (38) . In contrast, indomethacin blocked amplification of cAMP accumulation in mesangial cells by ET-1, and addition of exogenous 10 nM PGE2 restored the potentiation (Fig. 5) . Because this concentration of PGE2 was insufficient to activate adenylate cyclase, the effect of PGE2 was not additive but potentiating. This pathway for potentiating cAMP accumulation contrasts with the view that direct activation of adenylate cyclase by PGE2 receptors accounts for the vasorelaxant properties of PGE2 (16, 24) . Thus it appears that PGE2 can elevate intracellular cAMP in mesangial cells by two distinct pathways: (a) one pathway the result of direct activation of adenylate cyclase by PGE2; (b) the other due to potentiation by PGE2 of ( adrenergic-stimulated cAMP accumulation. It is interesting to note that potentiation by ET-1 approximately doubled the intracellular concentration of cAMP in the absence of IBMX (Fig. 5) , whereas to achieve a doubling by direct activation required the addition of > 10 AM exogenous PGE2 even in the presence of IBMX (24) . Given the well-documented role of cAMP to dampen smooth muscle cell contraction (25) , it seems possible that amplification of ( adrenergic-mediated cAMP accumulation by ET-1 could attenuate ET-1-induced contraction, but this hypothesis remains to be tested.
The biochemical mechanism by which PGE2 amplifies (- (40, 41) . Another possible mechanism would be inhibition of cAMP efflux by PGE2, PGA2, or PGAI. In certain cell types cAMP efflux is inhibited by PGA1 = PGA2 > PGE2 > PGF2a (42) (43) (44) , putatively via a glutathione conjugate of the prostaglandin (45) . Thus inhibition of cAMP export by ET-1 could result directly from PGE2 or from PGA2 formed by the nonenzymatic hydrolysis of PGE2. In the present experiments, the net effect of reduced cAMP efflux on the intracellular concentration of cAMP would be enhanced when adenylate cyclase activity was elevated by isoproterenol. Further experiments are necessary to determine the site(s) of action for the potentiating effect of ET-1-induced PGE2 synthesis on (3 adrenergic-stimulated cAMP accumulation in mesangial cells.
